Literature DB >> 12818414

Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men.

Camilla Skoglund-Andersson1, Ewa Ehrenborg, Rachel M Fisher, Gunilla Olivecrona, Anders Hamsten, Fredrik Karpe.   

Abstract

Low density lipoprotein (LDL) particle size is a genetically influenced trait associated with coronary heart disease (CHD). This study investigates the effects of genetic variation in plasma factors with important roles in lipoprotein metabolism on LDL heterogeneity. Common variants in the cholesteryl ester transfer protein (CETP-629C/A), lipoprotein lipase (LPL S447X), hepatic lipase (HL-480C/T) and apolipoprotein E (apoE e2/e3/e4) genes were studied in relation to LDL particle size distribution in 377 healthy, middle-aged men. A high-resolution polyacrylamide gradient gel electrophoresis technique was used to measure plasma concentrations of four LDL subfractions. The CETP-629A and LPL 447X alleles were associated with moderately increased LDL peak particle size. In contrast, the apoE e4 allele was associated with a marked reduction in LDL peak particle size and an increased relative proportion and plasma concentration of small, dense LDL. An interaction between the HL-480C/T and apo E polymorphisms contributed significantly to increased plasma concentration of small, dense LDL (LDL-III) in HL-480T carriers. In summary, the investigated polymorphisms were associated with diverse effects on the LDL particle size distribution, consistent with respect to protein function and proposed association with CHD risk. The observed associations were further modulated by gene-gene and gene-environment interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818414     DOI: 10.1016/s0021-9150(03)00016-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Atherogenic dyslipidemia: cardiovascular risk and dietary intervention.

Authors:  Kiran Musunuru
Journal:  Lipids       Date:  2010-06-04       Impact factor: 1.880

2.  Polymorphisms of genes in the lipid metabolism pathway and risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.

Authors:  Gabriella Andreotti; Jinbo Chen; Yu-Tang Gao; Asif Rashid; Bingshu E Chen; Philip Rosenberg; Lori C Sakoda; Jie Deng; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Robert Welch; Stephen Chanock; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02-22       Impact factor: 4.254

3.  Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk.

Authors:  Kiran Musunuru; Marju Orho-Melander; Michael P Caulfield; Shuguang Li; Wael A Salameh; Richard E Reitz; Göran Berglund; Bo Hedblad; Gunnar Engström; Paul T Williams; Sekar Kathiresan; Olle Melander; Ronald M Krauss
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-03       Impact factor: 8.311

4.  Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.

Authors:  Alexis C Wood; Stephen Glasser; W Timothy Garvey; Edmond K Kabagambe; Ingrid B Borecki; Hemant K Tiwari; Michael Y Tsai; Paul N Hopkins; Jose M Ordovas; Donna K Arnett
Journal:  Lipids Health Dis       Date:  2011-08-19       Impact factor: 3.876

5.  APOE, CETP and LPL genes show strong association with lipid levels in Greek children.

Authors:  M C Smart; G Dedoussis; E Louizou; M Yannakoulia; F Drenos; C Papoutsakis; N Maniatis; S E Humphries; P J Talmud
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-28       Impact factor: 4.222

6.  Interaction Effects of Lipoprotein Lipase Polymorphisms with Lifestyle on Lipid Levels in a Korean Population: A Cross-sectional Study.

Authors:  Jung-A Pyun; Sunshin Kim; Kyungchae Park; Inkyung Baik; Nam H Cho; Insong Koh; Jong-Young Lee; Yoon Shin Cho; Young Jin Kim; Min Jin Go; Eugene Shim; Kyubum Kwack; Chol Shin
Journal:  Genomics Inform       Date:  2012-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.